Pharmaceutical Dividends4iDnLTu5XbJm3jDXMix4LGTBz7t4M4s1o4hWwfzzpump
Case file · ante-mortem observation
FLATLINED.
Centralization, illiquidity, and mathematical inevitability
Grade Score
18/100
Grade F · FLATLINED
Holders
4
Liquidity DrainedFew HoldersNo VolumeHeavy Concentration
Field Report
Pharmaceutical Dividends: A Solana Tragedy
Here we observe the carcass of Pharmaceutical Dividends, a token that achieved the remarkable feat of dying before it truly lived. With four holders sharing complete ownership and zero liquidity, it represents nature's perfect example of financial natural selection—where ambition met mathematics and lost catastrophically.
Diagnosis
Activity
Flatlined
$0 volume / 24h.
Holders
Extreme cluster
Top 5 hold 100.0% of supply.
Cause
Likely Cause
Centralization, illiquidity, and mathematical inevitability
Patient Note
It promised dividends but delivered only a reminder that four whales cannot make a market, no matter how many authorities they revoke.
Holders
Top 1
97.7%
Top 5
100.0%
Top 10
100.0%
016xWf...Kb2x97.73%
02EqW3...rV8R1.36%
03xYz3...rshv0.50%
04H6Pj...1rAc0.41%